Effects of Converting Tacrolimus Formulation from Twice-Daily to Once-Daily in Liver Transplantation Recipients

Once- Versus Twice-Daily Tacrolimus

(2011) Katherine A. Barraclough et al.   DRUGS

Adherence in liver transplant recipients

(2011) Patrizia Burra et al.   LIVER TRANSPLANTATION

Lower Variability of Tacrolimus Trough Concentration After Conversion From Prograf to Advagraf in Stable Kidney Transplant Recipients

(2011) Ming-Ju Wu et al.   TRANSPLANTATION

Impact of the Conversion of the Immunosuppressive Regimen from Prograf to Advagraf or to Sirolimus in Long-term Stable Liver Transplant Recipients: Indications, Safety, and Outcome

(2011) A. Perrakis et al.   TRANSPLANTATION PROCEEDINGS

Once Daily Tacrolimus Formulation: Monitoring of Plasma Levels, Graft Function, and Cardiovascular Risk Factors

(2010) A. Meçule et al.   TRANSPLANTATION PROCEEDINGS

Safety of Conversion From Twice-Daily Tacrolimus (Prograf) to Once-Daily Prolonged-Release Tacrolimus (Advagraf) in Stable Liver Transplant Recipients

(2010) C. Comuzzi et al.   TRANSPLANTATION PROCEEDINGS

First Clinical Experience With the New Once-Daily Formulation of Tacrolimus

(2009) M Roy First   THERAPEUTIC DRUG MONITORING

Forty Years of Publication of Transplantation Proceedings—The Second Decade: The Cyclosporine Revolution

(2009) Barry D. Kahan   TRANSPLANTATION PROCEEDINGS

De Novo Kidney Transplant Recipients Need Higher Doses of Advagraf Compared With Prograf to Get Therapeutic Levels

(2009) M. Crespo et al.   TRANSPLANTATION PROCEEDINGS